DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer
暂无分享,去创建一个
S. Lakhani | K. Khanna | R. Freire | J. Saunus | L. Reid | S R Lakhani | K K Khanna | S Hernández-Pérez | E Cabrera | E Salido | M Lim | L Reid | J M Saunus | R Freire | E. Cabrera | E. Salido | S. Hernandez-Perez | M. Lim | Raimundo Freire | Sunil R. Lakhani | Eduardo Salido | Malcolm Lim | Lynne Reid
[1] Grant W. Brown,et al. A Role for USP7 in DNA Replication , 2013, Molecular and Cellular Biology.
[2] V. Smits,et al. USP7/HAUSP: A SUMO deubiquitinase at the heart of DNA replication , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.
[3] B. McConkey,et al. The origin recognition complex protein family , 2009, Genome Biology.
[4] M. Debatisse,et al. USP37 deubiquitinates Cdt1 and contributes to regulate DNA replication , 2016, Molecular oncology.
[5] Z. Szallasi,et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.
[6] Pier Paolo Pandolfi,et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network , 2008, Nature.
[7] R. Freire,et al. The Ddc2/ATRIP checkpoint protein monitors meiotic recombination intermediates , 2011, Journal of Cell Science.
[8] Zoi Lygerou,et al. The Human Licensing Factor for DNA Replication Cdt1 Accumulates in G1 and Is Destabilized after Initiation of S-phase* , 2001, The Journal of Biological Chemistry.
[9] J. Diffley,et al. DNA Replication and Oncogene-Induced Replicative Stress , 2014, Current Biology.
[10] Thanos D Halazonetis,et al. DNA replication stress as a hallmark of cancer. , 2015, Annual review of pathology.
[11] M. Fujita. Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells , 2006, Cell Division.
[12] 陽子 森,et al. 高等植物Origin recognition complexの機能解析 , 2004 .
[13] J. Julian Blow,et al. Replication licensing and cancer — a fatal entanglement? , 2008, Nature Reviews Cancer.
[14] L. Cooley,et al. Control of DNA Replication and Chromosome Ploidy by Geminin and Cyclin A , 2002, Molecular and Cellular Biology.
[15] V. Smits,et al. Dub3 controls DNA damage signalling by direct deubiquitination of H2AX , 2017, Molecular oncology.
[16] D. Karamitros,et al. Cdt1 and Geminin in cancer: markers or triggers of malignant transformation? , 2008, Frontiers in bioscience : a journal and virtual library.
[17] V. Speirs,et al. The potential utility of geminin as a predictive biomarker in breast cancer , 2013, Breast Cancer Research and Treatment.
[18] N. Mailand,et al. USP7 counteracts SCFβTrCP- but not APCCdh1-mediated proteolysis of Claspin , 2009, The Journal of cell biology.
[19] R. Freire,et al. USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination , 2014, Oncogene.
[20] W. Woodward,et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1 , 2014, Nature Cell Biology.
[21] Seiji Tanaka,et al. Deregulated G1-cyclin expression induces genomic instability by preventing efficient pre-RC formation. , 2002, Genes & development.
[22] René Bernards,et al. TSPYL5 suppresses p53 levels and function by physical interaction with USP7 , 2011, Nature Cell Biology.
[23] S. Hirota,et al. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers , 2016, Breast Cancer.
[24] V. Rotter,et al. Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation , 2014, Proceedings of the National Academy of Sciences.
[25] E. Lecona,et al. USP7 is a SUMO deubiquitinase essential for DNA replication , 2016, Nature Structural &Molecular Biology.
[26] Emmanuel Barillot,et al. TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer , 2013, PloS one.
[27] C. Robson,et al. Deubiquitinating enzymes as oncotargets , 2015, Oncotarget.
[28] F. Sola,et al. Essential role of human CDT1 in DNA replication and chromatin licensing. , 2002, Journal of cell science.
[29] Jamie R. Kutasovic,et al. Novel highly specific anti‐periostin antibodies uncover the functional importance of the fascilin 1‐1 domain and highlight preferential expression of periostin in aggressive breast cancer , 2016, International journal of cancer.
[30] B. Kessler. Selective and reversible inhibitors of ubiquitin-specific protease 7: a patent evaluation (WO2013030218) , 2014, Expert opinion on therapeutic patents.
[31] R. Freire,et al. Rad9B responds to nucleolar stress through ATR and JNK signalling, and delays the G1–S transition , 2012, Journal of Cell Science.
[32] M. Kirschner,et al. Geminin, an Inhibitor of DNA Replication, Is Degraded during Mitosis , 1998, Cell.
[33] V. Smits,et al. USP7 controls Chk1 protein stability by direct deubiquitination , 2014, Cell cycle.
[34] L. Komuves,et al. Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A , 2010, Nature Cell Biology.
[35] Y. Shang,et al. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis. , 2016, The Journal of clinical investigation.
[36] S. Lakhani,et al. Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer , 2014, Oncogenesis.
[37] T. Helleday,et al. Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress , 2013, Oncogene.
[38] S. Salghetti,et al. Destruction of Myc by ubiquitin‐mediated proteolysis: cancer‐associated and transforming mutations stabilize Myc , 1999, The EMBO journal.
[39] K. Helin,et al. Human Geminin promotes pre‐RC formation and DNA replication by stabilizing CDT1 in mitosis , 2004, The EMBO journal.
[40] Michael A. Gonzalez,et al. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell‐cycle progression , 2004, The Journal of pathology.
[41] Edward S. Miller,et al. USP7 is essential for maintaining Rad18 stability and DNA damage tolerance , 2016, Oncogene.
[42] Ying Zhang,et al. DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors , 2009, Cell cycle.
[43] M. Smolka,et al. PERK inhibits DNA replication during the Unfolded Protein Response via Claspin and Chk1 , 2017, Oncogene.
[44] J. Qin,et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.
[45] Limsoon Wong,et al. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer , 2015, Biology Direct.
[46] S. Lakhani,et al. ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype , 2015, Nature Communications.
[47] Yigong Shi,et al. Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway , 2006, PLoS biology.
[48] Anindya Dutta,et al. Rereplication by Depletion of Geminin Is Seen Regardless of p53 Status and Activates a G2/M Checkpoint , 2004, Molecular and Cellular Biology.
[49] Wenyi Wei,et al. DNA Damage Regulates UHRF1 Stability via the SCFβ-TrCP E3 Ligase , 2013, Molecular and Cellular Biology.
[50] B. Nicholson,et al. The Multifaceted Roles of USP7: New Therapeutic Opportunities , 2011, Cell Biochemistry and Biophysics.
[51] Anindya Dutta,et al. DNA replication in eukaryotic cells. , 2002, Annual review of biochemistry.
[52] Amit Kumar Srivastava,et al. USP7 modulates UV-induced PCNA monoubiquitination by regulating DNA polymerase eta stability , 2014, Oncogene.